Patents Assigned to Algonomics N.V.
  • Publication number: 20120202247
    Abstract: The present invention relates to a method for structure-based prediction of properties of peptides and peptide analogs in complex with major histocompatibility (MHC) class I and class II molecules. The said properties mainly relate to the three-dimensional structure of an MHC/peptide complex and the binding affinity of a peptide for an MHC receptor. The invention further relates to a computer program and a device therefor. The invention further relates to data produced by a method of the invention. The invention further relates to peptides and peptide analogs predicted to bind to target-MHC molecules. The present invention thus relates to the field of immunology, with possible applications in manufacture of vaccinates, de-immunization of proteins, and manufacture of therapeutic agents, especially immuno-therapeutic agents.
    Type: Application
    Filed: March 27, 2012
    Publication date: August 9, 2012
    Applicant: Algonomics N.V.
    Inventors: Ignace Lasters, Johan Desmet
  • Publication number: 20110245463
    Abstract: The present invention provides methods and apparatus for analyzing a protein structure.
    Type: Application
    Filed: February 3, 2011
    Publication date: October 6, 2011
    Applicant: AlgoNomics N.V.
    Inventors: JOHAN DESMET, IGNACE LASTERS, DOMINIQUE VLIEGHE, CARLO BOUTTON, PHILIPPE STAS
  • Patent number: 7702465
    Abstract: The present invention relates to a method for structure-based prediction of properties of peptides and peptide analogs in complex with major histocompatibility (MHC) class I and class II molecules. The properties mainly relate to the three-dimensional structure of an MHC/peptide complex and the binding affinity of a peptide for an MHC receptor. The invention further relates to a computer program and a device therefor. The invention further relates to data produced by a method of the invention. The invention further relates to peptides and peptide analogs predicted to bind to target-MHC molecules. The present invention thus relates to the field of immunology, with possible applications in manufacture of vaccinates, de-immunization of proteins, and manufacture of therapeutic agents, especially immunotherapeutic agents.
    Type: Grant
    Filed: June 10, 2003
    Date of Patent: April 20, 2010
    Assignee: Algonomics N.V.
    Inventors: Ignace Lasters, Johan Desmet
  • Publication number: 20050214857
    Abstract: The present invention is related to an isolated polypeptide micro-scaffold displaying immunoglobulin CDR2 or CDR3 polypeptide sequences, comprising a CDR2 or CDR3 polypeptide sequence interconnecting fragments of the adjacent framework polypeptide sequences, which are arranged to form two anti-parallel ?-strands. The present invention is further related to a method to search, select or screen for immunoglobulin CDR2 or CDR3 polypeptide sequences that bind to a given antigen or mixture of antigens, comprising the steps of: Creating a CDR library with the method of claim 13 from the genetic information of an individual or group of individuals; Select a CDR, which binds to said antigen or mixture of antigens.
    Type: Application
    Filed: December 11, 2002
    Publication date: September 29, 2005
    Applicants: Algonomics N.V., ABLYNX N.V.
    Inventors: Ignace Lasters, Jurgen Pletinckx, Nathalie Boutonnet, Marc Lauwereys, Els Beirnaert